BAP1 and cutaneous melanoma: However, patients carrying germline BAP1 mutations in PMe [100, 101, 102] and cutaneous melanoma [103] show an improved survival and a better prognosis, suggesting that the presence of a mutated BAP1 might mitigate tumour aggressiveness (a “friendly” aspect).